K-beauty companies targeting the Japanese market have concluded that online advertising alone has limits in converting purchases, and are shifting their strategies toward creating more opportunities for consumers to try products in person. eBay Japan opened a permanent experiential space in Shibuya spanning two floors and about 120 pyeong, creating a structure that reconnects sampling experiences with online reviews. This change is being driven by consumers no longer viewing cosmetics and health functional foods separately, but instead managing both inner and outer wellness together. As of the first half of this year, inner beauty sales have grown by an average of 110% annually over the past three years, while distributors are strengthening experiences and curation and brands are expanding their portfolios from beauty into wellness...

The focus of new drug approval is shifting away from simply increasing the number of clinical trial phases and toward also considering patient recruitment feasibility and the lack of treatment alternatives. A representative example is Repliktu, which received full approval based on data from a single-arm Phase 1/2 trial, and is seen as a case where, for rare patient populations, practical development feasibility and medical necessity were considered alongside uniform confirmatory trial requirements. This trend is also extending to other development strategies. In Korea, there are growing efforts to improve development efficiency by reflecting interim results through approaches such as adaptive 2b/3 trials, while in Japan, conditional and time-limited approval combined with insurance coverage for regenerative medicine products is being used to pursue commercialization and evidence accumulation at the same time.

Health management is rapidly moving away from the model of visiting a hospital only after symptoms appear and toward anticipating risks in advance based on data accumulated in daily life. Samsung Galaxy Watch’s heart health score and Handok’s sleep business strategy show efforts to integrate indicators such as sleep, activity levels, and heart rate into a single management flow... This trend is expanding beyond device makers and pharmaceutical companies to collaboration involving insurers and medical technology firms as well. The business agreement between Philips Korea and Huray Positive, along with insurers’ focus on women’s life-cycle needs, suggests that health management services are shifting from a supplementary feature for selling coverage to a core tool for long-term customer relationships and risk management...

The center of gravity in the natural products industry is shifting from individual corporate laboratories to shared regional infrastructure. With the opening of an open testing lab in the Yeongnam region that provides access to equipment and testing facilities difficult for small and medium-sized firms to secure on their own, barriers to R&D entry for regional companies with limited accessibility are being lowered. This trend is extending beyond research support to the relocation of production bases as well. Companies are investing KRW 13 billion to build new health functional food manufacturing plants, while local governments are expanding overseas sales channels based on achievements such as export contracts worth USD 4.19 million, making it increasingly clear that they aim to connect region-based industries to actual revenue and employment.

The health functional food and inner beauty markets are rapidly shifting from long-term, regimen-based products to instantly consumable formats such as gummies, shots, and protein products. This change is not only broadening consumer touchpoints in the domestic market, but also accelerating market restructuring as overseas sales become a central driver of growth. As distribution channels expand from specialty stores to everyday lifestyle platforms and curated retail shops, products are now competing less on function alone and more on portability, user experience, and fit with consumer preferences. As a result, manufacturers are moving beyond simple production toward planning and formulation development, while brands are expanding their business boundaries from cosmetics into ingestible beauty products...

Starting November 20, colleges of pharmacy will be required to undergo curriculum evaluation and accreditation, and those that fail to meet the standards may be barred from admitting new students. As quality control mechanisms previously applied to other medical fields are extended to pharmacy education, the educational conditions and operational standards of pharmacy schools will be directly compared at the admissions stage. This change is more than a simple tightening of administrative procedures; it is closer to a public review of the credibility of education before student selection. For applicants, it provides more information for choosing schools, while for universities, it increases the burden of aligning academic operations, facilities, and performance with actual standards.

As products targeting everyday health concerns such as better sleep and weight management spread rapidly, the risks of supplements and injections used outside medical supervision have also grown. In particular, products promoted through overseas direct purchases and social media advertising, such as gummies containing ashwagandha root extract, as well as obesity treatments used outside prescription controls, have shown that they can lead to serious adverse reactions such as acute pancreatitis. This trend can be seen as the result of a combination of the perception that natural substances or health functional foods are relatively mild and consumer demand for quick results. The key issue is that risk can vary greatly depending not just on whether a product is effective, but also on the duration of use, dosage, concomitant medications, and distribution channels; accordingly, prior verification and consultation have now become more important than freedom of choice alone.

In the beauty market, a strong trend has emerged in which sales performance in distribution channels, rather than laboratories or advertising, serves as the first proof of a product’s credibility. As Daiso has expanded its cosmetics assortment to more than 2,200 items, it has become a starting point where overseas buyers directly discover products and manufacturers, while Olive Young is increasingly functioning as an on-site showroom for visitors to Korea as foreign offline purchases grow rapidly. This shift has occurred because brands are moving beyond simple shelf-placement competition and are beginning to use distribution networks themselves as tools for export validation and data collection. As companies also expand models that combine content and sales, such as AI- and XR-based wellness inner beauty tech platforms, distribution is evolving beyond a sales outlet into core infrastructure that shapes product planning and overseas expansion.

Auto insurance has shifted toward more stringent management of treatment for minor injuries. In particular, patients with minor injuries classified as injury grades 12 to 14 must now undergo external review if they seek treatment beyond eight weeks, putting the brakes on the customary practice of prolonged treatment. This change is less about simply reducing some medical services and more about controlling accumulated insurance payouts. For minor injury patients, it effectively blocks the broadly recognized payment of future treatment costs during settlements, with the aim of realigning actual medical necessity and the scope of compensation.